| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 | 
| 03/19/1997 | CN1145409A Tissue culture method using polypropylene film bag as tissue culture packing vessel | 
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same | 
| 03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes | 
| 03/18/1997 | US5612213 Vector for increased expression of recombinant factor viii | 
| 03/18/1997 | US5612211 Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors | 
| 03/18/1997 | US5612207 Red blood cell | 
| 03/18/1997 | US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells | 
| 03/18/1997 | US5612205 Producing dna segments | 
| 03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine | 
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors | 
| 03/18/1997 | US5612190 Screening for vasodilators | 
| 03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies | 
| 03/13/1997 | WO1997009616A1 Stain and capillary slide to detect animal and plant cells | 
| 03/13/1997 | WO1997009600A2 Method of isolating cells | 
| 03/13/1997 | WO1997009445A1 Methods and compositions for development of drug screening procedures and diagnostic tools | 
| 03/13/1997 | WO1997009442A1 Targeted nucleotide sequence delivery and integration system | 
| 03/13/1997 | WO1997009441A2 Improved aav vectors for gene therapy | 
| 03/13/1997 | WO1997009440A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells | 
| 03/13/1997 | WO1997009435A1 Plasmid stabilization | 
| 03/13/1997 | WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis | 
| 03/13/1997 | WO1997009427A1 Vegf-related protein | 
| 03/13/1997 | WO1997009426A1 Rna polymerase transcription factor | 
| 03/13/1997 | WO1997009419A1 Monoclonal lymphocytes and methods of use | 
| 03/13/1997 | WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor | 
| 03/13/1997 | WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins | 
| 03/13/1997 | WO1997008946A1 Medium composition for external fertilization | 
| 03/13/1997 | WO1997006268A3 Dna constructs | 
| 03/13/1997 | WO1997006267A3 Genetic transformation using a parp inhibitor | 
| 03/13/1997 | WO1997005256A3 Mammalian pro-hormone convertase | 
| 03/13/1997 | WO1997005170A3 Broad specificity antibodies | 
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide | 
| 03/13/1997 | WO1996033279A3 Repertoire cloning process, products derived therefrom and uses for said products | 
| 03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis | 
| 03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis | 
| 03/13/1997 | CA2231788A1 Targeted nucleotide sequence delivery and integration system | 
| 03/13/1997 | CA2231400A1 Vegf-related protein | 
| 03/13/1997 | CA2230889A1 Stain and capillary slide to detect animal and plant cells | 
| 03/13/1997 | CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor | 
| 03/13/1997 | CA2230758A1 Improved aav vectors for gene therapy | 
| 03/13/1997 | CA2230593A1 Rna polymerase transcription factor | 
| 03/13/1997 | CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins | 
| 03/12/1997 | EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces | 
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) | 
| 03/12/1997 | EP0761233A2 Transkaryotic implantation | 
| 03/12/1997 | EP0761231A1 Vaccine composition containing adjuvants | 
| 03/12/1997 | EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch | 
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels | 
| 03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation | 
| 03/12/1997 | EP0760857A1 Receptor for oncostatin m | 
| 03/12/1997 | EP0760855A1 Hepatitis c virus asialoglycoproteins | 
| 03/12/1997 | EP0760853A1 Methods and associated reagents for detecting modulators of cytokine action | 
| 03/12/1997 | EP0760851A1 Tumor necrosis factor receptor-associated factors | 
| 03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) | 
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses | 
| 03/12/1997 | EP0644774A4 Improved production of reproductive hormones. | 
| 03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies | 
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides | 
| 03/12/1997 | CN1145020A Ancient organisms | 
| 03/12/1997 | CN1034242C Method and apparatus for screening cells or formed bodies | 
| 03/11/1997 | US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines | 
| 03/11/1997 | US5610281 Monoclonal antibody which specifically binds to human e-cadherin | 
| 03/11/1997 | US5610280 Antitumor | 
| 03/11/1997 | US5610279 Human TNF receptor | 
| 03/11/1997 | US5610058 Cytotrophoblast antigen and monoclonal antibodies which specifically bind cytotrophoblast cells | 
| 03/11/1997 | US5610056 Generation of erythroid cells from hematopoietic stem cells | 
| 03/11/1997 | US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus | 
| 03/11/1997 | US5610051 Dissecting immature seed and removing megagametophyte, placing megagametophyte on a culture medium, isolating and extracting embryos from extruded tissue and transferring embryos to a culture medium | 
| 03/11/1997 | US5610042 Bombardment of plant embryo with microprojectile dna coated particles | 
| 03/11/1997 | US5610041 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants | 
| 03/11/1997 | US5610031 B1k chain of laminin and methods of use | 
| 03/11/1997 | US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors | 
| 03/11/1997 | US5610007 Chimeric sheets of epithelial cells | 
| 03/11/1997 | US5609873 Treatment of psoriasis and other skin disorders associated with keratinocyte differentiation | 
| 03/06/1997 | WO1997008560A1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE | 
| 03/06/1997 | WO1997008335A1 Monoclonal antibody recognizing serum amyloid a | 
| 03/06/1997 | WO1997008331A1 Stimulation of homologous recombination in eukaryotic organisms or cells by recombination promoting enzymes | 
| 03/06/1997 | WO1997008328A1 Selective elimination of t cells that recognize specific preselected targets | 
| 03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders | 
| 03/06/1997 | WO1997008320A1 Protein/(poly)peptide libraries | 
| 03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease | 
| 03/06/1997 | WO1997008313A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production | 
| 03/06/1997 | WO1997008311A1 Novel procollagens | 
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof | 
| 03/06/1997 | WO1997008307A1 Heterologous protein production system using avian cells | 
| 03/06/1997 | WO1997008295A1 Reconstituted skin | 
| 03/06/1997 | WO1997008293A1 Release of intracellular material | 
| 03/06/1997 | WO1997008291A1 Apparatus and methods for culturing biological material | 
| 03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes | 
| 03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor | 
| 03/06/1997 | WO1997008196A1 Neurturin and related growth factors | 
| 03/06/1997 | WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity | 
| 03/06/1997 | WO1997007817A1 Multi-subtype fiv vaccines | 
| 03/06/1997 | WO1997007674A1 Methods and compositions for the selective modification of nucleic acids | 
| 03/06/1997 | WO1997007669A1 Quiescent cell populations for nuclear transfer | 
| 03/06/1997 | WO1997007668A1 Unactivated oocytes as cytoplast recipients for nuclear transfer | 
| 03/06/1997 | WO1997007666A1 Electroporation-mediated molecular transfer in intact plants | 
| 03/06/1997 | WO1997005255A3 Helper viruses for preparing recombinant viral vectors | 
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections | 
| 03/06/1997 | WO1996040929A3 Transferrin receptor genes |